Edwards Lifesciences (EW) PT Lowered to $118 at Barclays on 3Q; 'Quarter Over Quarter Slowdown in U.S. TAVR Growth'
Tweet Send to a Friend
Barclays lowered its price target on Edwards Lifesciences (NYSE: EW) to $118.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
